1. Hirshberg B, Livi A, Bartlett D, et al. Forty-eight-hour Fast: The Diagnostic Test for Insulinoma. J Clin Endo and Metab 2000; 85(9): 3222-3226.

2. Dolan JP, Norton JA. Occult insulinoma. Br J Surg 2000; 87(4):385-387.

3. Kaplan EL, Arganini M, Kang SJ. Diagnosis and treatment of hypoglycemic disorders. Surg Clinics N Am 1987; 67(2): 395-410.

4. Marks V, Teale JD. Investigation of Hypoglycaemia. Clin Endo 1996; 44(2): 133-6.

5. Service FJ, Natt N. The Prolonged Fast. J Clin Endo and Metab 2000; 85(11): 3973-3974.

6. Grant CS. Surgical aspects of hyperinsulinemic hypoglycemia. Endo & Metab Clin N Am 1999; 28(3): 533-54.

7. Service FJ. Classification of hypoglycemic disorders. Surg Clinics N Am 1999; 28(3): 501-17.

8. Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endo & Metab Clin N Am 1999; 28(3): 495-500.

9. Roith DL. Tumor-Induced Hypoglycemia. N Engl J Med 1999; 341(10): 757-758.

10. Dizon AM, Kowalyk S, Hoogwerf BJ. Neuroglycopenic and Other Symptoms in Patients with Insulinomas. Am J Med 1999; 106(3): 307-10.

11. Grant CS. Insulinoma. Surg Onc Clin N Am 1998; 7(4): 819-44.

12. VanHeerden JA, Edis AJ, Service FJ. The surgical aspects of insulinomas. Ann Surg 1979; 189(6): 677-82.

13. Service FJ. Medical Progress: Hypoglycemic Disorders. N Engl J Med 1995; 332(17): 1144-1152.

14. Service FJ. Clinical review 42: Hypoglycemias. J Clin Endo & Metab 1993; 76(2): 269-72.

15. Thompson GB, Service FJ, Andrews JC, et al. Surgery 2000; 128(6): 937-44.

16. Marks V, Teale JD. Tumours producing hypoglycaemia. Diab-Metab Reviews 1991; 7(2): 79-91.

17. Witteles RM, Straus FH, Sugg SL, et al. Adult-Onset Nesidioblastosis Causing Hypoglycemia: An Important Clinical Entity and Continuing Treatment Dilemma. Arch Surg 2001; 136(6): 656-663.

18. Service FJ, McMahon MM, O’Brien PC, et al. Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66: 711-719.

19. Morrison H. Contributions to the microscopic anatomy of the pancreas by Paul Langerhans [Berlin, 1869; translated from the German]. Bull Hist Med 1937; 5: 259-267.

20. Banting FG, Best CH. The internal secretion of the pancreas. J Lab Clin Med 1922; 7: 251-266.

21. Wilder RM, Allan FN, Power MH et al. Carcinoma of the islets of the pancreas: hyperinsulinism and hypoglycemia. JAMA 1927; 89: 348-355.

22. Grama D, Eriksson B, Martensson H et al. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg 1992; 16: 632-639.

23. Service FJ, Dale AJD, Elveback LR et al. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 1976; 51: 417-429.

24. Ardengh HC, Rosenbaum P, Ganc AJ, et al. Role of EUS in the preoperative localization of insulinomas compared with spiral CT. Gastro Endo 2000; 51(5): 552-5.

25. Rothmund M, Angelini L, Brunt LM, et al. Surgery for benign insulinoma: an international review. World J Surg 1990; 14: 393-99.

26. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastro 2000; 95(9): 2271-77.

27. Brandle M, Pfammatter T, Spinas GA, et al. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumors. Clin Endocrinol 2001; 55(3): 357-62.

28. Gunther RW, Klose KJ, Ruckert K, et al. Localization of small islet-cell tumors. Preoperative and intraoperative ultrasound, computed tomography, arteriography, digital subtraction angiography, and pancreatic venous sampling. Gastro Radiol 1985; 10(2): 145-52.

29. Norton JA, Shawker TH, Doppman JL, et al. Localization and surgical treatment of occult insulinomas. Ann Surg 1990; 212(5): 615-20.

30. Huai J, Zhang W, Niu H, et al. Localization and surgical treatment of pancreatic insulinomas guided by intraoperative ultrasound. Am J Surg 1998; 175(1): 18-21.

31. Norton JA, Cromack DT, Shawker TH, et al. Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg 1988; 207(2): 160-8.

32. Moore NR, Rogers CE, and Britton BJ. Magnetic resonance imaging of endocrine tumours of the pancreas. Br J Rad 1995; 68(808): 341-7.

33. Vinik AI, Delbridge L, Moattari R, et al. Transhepatic portal vein catheterization for localization of insulinomas: a ten-year experience. Surgery 1991; 109(1): 1-11; discussion 111.

34. Richards ML, Gauger PG, Thompson NW, et al. Pitfalls in the surgical treatment of insulinoma. Surgery 2002; 132(6): 1040-9.

35. Hiramoto JS, Feldstein VA, LaBerge JM and Norton JA. Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001; 136(9): 1020-26.

36. Berber E, Flesher N, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002; 26(8): 985-90.

37. Norton JA. Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Onc 1999; 10 Suppl 4: 182-4.

38. Gorden P, Skarulis MC, Roach P, et al. Plasma proinsulin-like component in insulinoma: a 25-year experience. J Clin Endocrinol Metab 1995; 80: 2884-7.

39. Whipple A. The surgical therapy of hyperinsulinism. J Int Chir 1938; 3: 237-276.

40. Whipple AO, Frantz VK. Adenoma of islet cell tumors with hyperinsulinism. Am Surg 1935; 101: 1299-1335.

41. Stefanini P, Carboni M, Patrassi N. Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery 1974; 75: 597-609.

42. Anderson N, Lokich J. Mesenchymal tumors associated with hypoglycemia: Case report and review of the literature. Cancer 1979; 44:787-90.

43. Laidlaw GF. Nesidioblastosis: The islet cell tumor of the pancreas. Am J Pathol 1937; 14: 125-139.

44. Thomas P. Genetic mutations as a cause of hyperinsulinemic hypoglycemia in children. Endocrinol Metab Clin North Am 1999; 28: 647-656.

45. Harness JK, Geelhoed GW, Thompson NW, et al. Nesidioblastosis in adults: a surgical dilemma. Arch Surg 1981; 116: 575-80.

46. Jaffe R, Hashida Y, Yunis EJ. Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest 1980; 42: 356-65.

47. Mozell EJ, Woltering EA, O’Dorisio TM, et al. Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with sandostatin. Am J Gastoenterol 1990; 86: 181-88.

48. Seckl M, Mulholland P, Bishop A, et al. Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 1999; 341: 733-36.

49. McFadzean A, Yeung R. Further observations on hypoglucaemia in hepatocellular carcinoma. Am J Med 1969; 47: 220-235.

50. Chowdhury F, Bleicher S. Studies of tumor hypoglycemia. Metabolism 1973; 22: 663-74.

51. Daughaday W. The pathophysiology of IGF-II hypersecretion in non-islet cell tumor hypoglycemia. Diabetes Rev 1995; 3: 62-72.

52. Moller N, Blum W, Mengel A, et al. Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia; evidence for increased muscle glucose uptake. Diabetologia 1991; 34: 17-20.

53. Silbert C, Rossini A, Ghazvinian S, et al. Tumor hypoglycemia: Deficient splanchnic glucose output and deficient glucagon secretion. Diabetes 1976; 25: 202-206.

54. Chung J, Henry R. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab 1996; 81: 919-25.

55. Nicholls AG. Simple adenoma of the pancreas arising from an islet of Langerhans. J Med Res 1902; 8: 385.

56. Fletcher A, Campbell W. The blood sugar following insulin administration and the symptom complex-hypoglycemia. J Metab Res 1922; 2: 637.

57. Robbins DC, Tager HS, Rubenstein AH. The biologic and clinical importance of proinsulin. N Engl J Med 1984; 310: 165-75.

58. Starr JI, Rubenstein AH. Metabolism of endogenous proinsulin and insulin in man. J Clin Endocrinol Metab 1974; 38: 305-7.

59. Fajans SS, Vinik AI. Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am 1989; 18: 45-74.

60. Service FJ. Diagnostic approach to adults with hypoglycemic disorders. Endocrinol Metab Clin North Am 1999; 28: 519-32.

61. O’Brien T, O’Brien PC, Service FJ. Insulin surrogates in insulinoma. J Clin Endocrinol Metab 1993; 77: 448-51.

62. Service FJ, O’Brien PC, Kao PC, et al. C-peptide suppression test: effects of gender, age, and body mass index: implications for the diagnosis of insulinoma. J Clin Endocrinol Metab 1992; 74: 204-210.

63. McMahon MM, O’Brien PC, Service FJ. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. Mayo Clin Proc 1989; 64: 1481-8.

64. Dunnick NR, Long JA, Krudy A. Localizing insulinomas with combined radiographic methods. Am J Roentgenol 1980; 135: 747-52.

65. Fulton RE, Sheedy PT, McIlrath DC. Preoperative angiographic localization of insulin-producing tumors of the pancreas. Am J Roentgenol 1975; 123: 367-77.

66. Angelini L, Bezzi M, Tucci G, et al. The ultrasonic detection of insulinomas during surgical exploration of the pancreas. World J Surg 1987; 11: 642-647.

67. Gower WR, Fabri PJ. Endocrine neoplasms (non-gastrin) of the pancreas. Semin Surg Oncol 1990; 6: 98-109.

68. Dagget PR, Goodburn EA, Kurtz AB, et al. Is preoperative localization of insulinomas necessary? Lancet 1981; 1: 483-486.

69. Pasieka JL, McLeod MK, Thompson NW, et al. Surgical approach to insulinomas: assessing the need for preoperative localization. Arch Surg 1992; 127: 442-447.

70. Grant CS, vanHeerden JA, Charboneau JW, et al. Insulinoma: the value of intraoperative ultrasonography. Arch Surg 1988; 123: 843-48.

71. Hirshberg B, Libutti SK, Alexander HR, et al. J Am Coll Surg 2002. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure; 194(6): 761-4.

72. Thompson GB, Service FJ, vanHeerden JA, et al. Reoperative insulinomas, 1927-1992: an institutional experience. Surgery 1993; 114: 1196-1206.

73. Doherty GM, Doppman JL, Shawker TH, et al. Results of a prospective strategy to diagnose, localize and resect insulinomas. Surgery 1991; 110: 989-997.

74. Menegaux F, Schmitt G, Mercadier M, et al. Pancreatic insulinomas. Am J Surg 1992; 165: 243-48.

75. Hoff AO, Vassilopoulou-Sellin R. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer 1998; 82(8): 1585-92.

76. Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol & Metab Clin North Am 1999; 28(3): 495-500.

77. Phan GQ, Yeo CJ, Cameron JL, et al. Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: fifty patients. Surgery 1997; 122(6): 989-96.

78. Schumacker B, Lubke HJ, Frieling T, et al. Prospective study on the detection of insulinomas by endoscopic ultrasonography. Endoscopy 1996; 28(3): 273-6.

79. Boukhman mp, Karam JM, Shaver J, Siperstein AE, et al. Localization of insulinomas. Arch Surg 1999; 134: 818-23.

80. Shawker TH, Norton JA, Oldfield EH. The use of intraoperative ultrasound during cancer surgery. In Important Advances in Oncology. VT Devita, S Hellman, SA Rosenberg, editors. Philadelphia, Lippincott, 1992.

81. Kato M, Doi R, Imamura M, et al. Response to human insulinoma cells to extracellular calcium is different from normal B cells. Digest Dis & Sci 1998; 43(11): 2429-38.

82. Chavan A, Kirchhoff TD, Brabant G, et al. Role of the intra-arterial calcium stimulation test in the preoperative localization of insulinomas. Eur Rad 2000; 10(10): 1582-6.

83. Marks V. Hypoglycemia—real and unreal, lawful and unlawful: The 1994 Banting Lecture. Diabet Med 1995; 12: 850-64.

84. Felig P, Cherif A, Minegawa A, et al. Hypoglycemia during prolonged exercise in normal man. N Engl J Med 1982; 306: 895-900.

85. Biochem text ref

86. Billington C, Casciato D, Choquette D, et al. Artifactual hypoglycemia associated with polycythemia vera. JAMA 1983; 249: 774-75.

87. Goodenow T, Malarkey W. Leukocytosis and artifactual hypoglycemia. JAMA 1977; 237: 1961-62.

88. Jarrett R. The cardiovascular risk associated with impaired glucose tolerance. Diabet Med 1996; 13(suppl): 15-19.

89. Owen O, Morgan A, Kemp H, et al. Brain metabolism during fasting. J Clin Invest 1967; 46: 1589-95.

90. Mitrakao A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991; 260: E67-E74.

91. Towler D, Havlin C, Craft S, et al. Mechanism of awareness of hypoglycemia: Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 1993; 42: 1791-98.

92. Pladziewicz D, Nesto R. Hypoglycemia-induced silent myocardial ischemia. Am J Cardiol 1989; 63: 1531-32.

93. Perros P, Frier B. The long-term sequelae of severe hypoglycemia on the brain in insulin-dependent diabetes mellitus. Horm Metab Res 1997; 29: 197-202.

94. Bolli G, DeFeo P, Perriello G, et al. Role of hepatic autoregulation in defense against hypoglycemia in humans. J Clin Invest 1985; 75: 1623-31.

95. Mitrakou A, Fannelli C, Veneman T, et al. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med 1993; 329: 834-39.

96. Korytkowski M, Mokan M, Veneman T, et al. Reduced -adrenergic sensitivity in patents with type I diabetes and hypoglycemia unawareness. Diabetes Care 1998; 21: 1939-43.

97. Boyle P, Nagy R, O’Connor A, et al. Adaptation of brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci USA 1994; 91: 9352-56.

98. Boyle P, Schwartz N, Shah S, et al. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 1988; 318: 1487-92.

99. Marker J, Cryer P, Clutter W. Attenuated glucose recovery from hypoglycemia in the elderly. Diabetes 1992; 41: 671-78.

100. Amiel S, Maran A, Powrie J, et al. Gender differences in counterregulation to hypoglycaemia. Diabetologia 1993; 36: 460-64.

101. Hirsch I, Boyle P, Craft S, et al. Higher glycemic thresholds for symptoms during -adrenergic blockade in IDDM. Diabetes 1991; 40: 1177-86.

102. Rosenn B, Miodovnik M, Khoury J, et al. Counterregulatory hormonal responses to hypoglycemia during pregnancy. Obstet Gynecol 1996; 87: 568-74.

103. Bottini P, Boschetti E, Pampanelli S, et al. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM. Evidence for a nonselective defect. Diabetes 1997; 46: 814-23.

104. Consoli A, Kennedy F, Miles J, et al. Determination of Krebs Cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall hepatic glucose output in man. J Clin Invest 1987; 80: 1303-10.

105. Stumvoll M, Meyer C, Mitrakou A, et al. Renal glucose production and utilization: New aspects in humans. Diabetologia 1997; 40: 749-57.

106. Landau B, Wahren J, Chandramouli V, et al. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 1996; 98: 378-85.

107. Kennedy F, Bolli G, Go V, et al. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987; 64: 602-08.

108. Gerich J, Campbell P. Overview of counterregulation and its abnormalities in diabetes mellitus and other conditions. Diabetes Metab Rev 1988; 4: 93-111.

109. White N, Skor D, Cryer P, et al. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 1983; 308: 485-91.

110. Lecavalier L, Bolli G, Cryer P, et al. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulation in normal humans. Am J Physiol 1989; 256: E844-E851.

111. DeFeo P, Perriello G, Torlone E, et al. Contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol 1991; 261: E725-E736.

112. Fanelli C, DeFeo P, Perriello G, et al. Adrenergic mechanisms contribute to the late phase of glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 1992; 89: 2005-13.

113. McMahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabet Metab Rev 1988; 4: 17-30.

114. Seltzer H. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18: 163-183.

115. Arky R. Hypoglycemia associated with liver disease and ethanol. Endocrinol Metab Clin North Am 1989; 18: 75-90.

116. Madison L. Ethanol-induced hypoglycemia. In Levine R, Luft R (eds): Advances in Metabolic Disorders, vol 3. New York, Academic, 1968, pp 85-109.

117. Flanagan D, Wood P, Sherwin R, et al. Gin and tonic and reactive hypoglycemia: What is important—the gin, the tonic, or both? J Clin Endocrinol Metab 1998; 83: 796-800.

118. Siler S, Neese R, Christiansen M, et al. The inhibition of gluconeogenesis following alcohol in humans. Am J Physiol 1998; 275: E897-E907.

119. Krebs H, Freedland R, Stubbs M. Inhibition of hepatic gluconeogenesis by ethanol. Biochem J 1969; 112: 117-24.

120. Reith D, Dawson A, Epid D, et al. Relative toxicity of beta blockers in overdose. Clin Toxicol 1996; 34: 273-8.

121. Poretsky L, Moses A. Hypoglycemia associated with trimethoprim/sulfamethoxazole therapy. Diabetes Care 1984; 7: 508-9.

122. Rizza R, Cryer P, Haymond M, et al. Adrenergic mechanisms for the effect of epinephrine on glucose production and clearance in man. J Clin Invest 1980; 65: 682-9.

123. Baron S. Salicylates as hypoglycemic agents. Diabetes Care 1982; 5: 64-71.

124. Bouchard P, Sai P, Reach G, et al. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 1982; 31: 40-5.

125. Mizock B. Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98: 75-84.

126. Kinney J. Metabolic responses of the critically ill patient. Crit Care Clin 1995; 11: 569-85.

127. Chiolero R, Revelly J, Tappy L. Energy metabolism in sepsis and injury. Nutrition 1997; 13(suppl): 45-51.

128. Hinshaw L. Concise review: The role of glucose in endotoxin shock. Circ Shock 1976; 3: 1-10.

129. Brady W, Butler K, Fines R, et al. Hypoglycemia in multiple trauma victims. Am J Emerg Med 1999; 17: 4-5.

130. Lang C, Bagby G, Blakesley H, et al. Importance of hyperglucagonemia in eliciting the sepsis-induced increase in glucose production. Circ Shock 1989; 29: 181-91.

131. Wichterman K, Chaudry I, Baue A. Studies of peripheral glucose uptake during sepsis. Arch Surg 1979; 114: 740-45.

132. Meszaros K, Lang C, Bagby G, et al. In vivo glucose utilization by individual tissues during nonlethal hypermetabolic sepsis. FASEB J 1988; 2: 3083-86.

133. Hedayati H, Beheshti M. Profound spontaneous hypoglycaemia in congestive heart failure. Curr Med Res Opin 1977; 4: 501-4.

134. Marks V, Rose F. Hypoglycemia, ed 2. Oxford, Blackwell, 1981.

135. Gerich J. Glucose counterregulation and its impact on diabetes mellitus. Diabetes 1988; 37: 1608-1617.

136. Service FJ, McMahon MM, O’Brien PC, et al. Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66: 711-19.

137. Creutzfeldt W, Arnold R, Creutzfeldt C, et al. Biochemical and morphological investigations of 30 human insulinomas. Diabetologica 1973; 9: 217-31.

138. Danforth DN Jr, Gorden P, Brennan MF. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 1984; 96: 1027-36.

139. Kahn RC, Rosen SW, Weintraub BD, et al. Ectopic production of chorionic gonaditropin and its subunits by islet-cell tumors: a specific marker for malignancy. N Engl J Med 1977; 297: 565-69.

140. Chung DC, Smith AP, Louis DN, et al. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 1997; 100: 404-10.

141. McEntee GP, Nagorney DM, Kvols LK, et al. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108: 1091-96.

142. Que FG, Nagorney DM, Batts KP, et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169: 36-43.

143. Moertel CG, Lefkopoulo M, Lipsitz S. Streptozocin-doxorubicin, streptozocin-fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992; 326: 519-23.

144. Fajans SS, Floyd JC Jr, Thiffault CA. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man. Ann NY Acad Sci 1968; 150: 261-80.

145. Goode PN, Farndon JR, Anderson J, et al. Diazoxide in the management of patients with insulinoma. World J Surg 1986; 10: 586-92.

146. Moore TJ, Peterson LM, Harrington DP, et al. Successful arterial embolization of an insulinoma. JAMA 1982; 248: 1353-57.

147. Uflacker R. Arterial embolization as definitive treatment for benign insulinoma of the pancreas. J Vasc Interv Radiol 1992; 3(4): 639-44.

148. Chen H, Hardacre JM, Uzar A, et al. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Col Surg 1998; 187(1): 88-92.

149. Lo CY, vanHeerden JA, Thompson GB, et al. Islet cell carcinoma of the pancreas. World J Surg 1996; 20(7): 878-83.

150. Demeure MJ, Klonoff DC, Karam JH, et al. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery 1991; 110(6): 998-1004.

151. Hashimoto LA, Walsh RM. Preoperative localization of insulinomas is not necessary. J Am Col Surg 1999; 189(4): 368-73.

152. Simon D, Starke A, Goretzki PE, et al. Reoperative surgery for organic hyperinsulinism: indications and operative strategy. World J Surg 1998; 22(7): 666-71.

153. Lo CY, Lam KY, Fan ST. Surgical strategy for insulinomas in multiple endocrine neoplasia type I. Am J Surg 1998; 175(4): 305-7.

154. Brown CK, Bartlett DL, Doppman JL, et al. Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. Surgery 1997; 122(6): 1189-93.

155. Rushakoff RJ, Lewis SB: Case of Pseudohypoglycemia. Diabetes Care 2001 24: 2157-2158.

156. Mann FC, Magath TB. Studies on the physiology of the liver. II. The effect of the removal of the liver on blood sugar level. Arch Intern Med 1922; 30:73.

157. Zimmerman HG, Thomas LJ, Scherr EH. Fasting blood sugar in hepatic disease with reference to infrequency of hypoglycemia. Arch Intern Med 1953, 091L 577-584.

158. Fisher KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients: Causes and outcomes. N Eng J Med 1986; 315:1245-1250

159. Frizzell M, Larsen PR, Field JB: Spontaneous hypoglycemia associated with chronic renal failure. Diabetes 1973; 22:493-498.

160. Earle K, Rushakofdf RJ, Goldfine I: Case Report: Inadvertent Sulfonylurea over dosage and hypoglycemia in an elderly woman: Failure of serum hypoglycemia screening. Diabetes Technology and Therapeutics 5: 449-451, 2003.